Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence
Not Applicable
Completed
- Conditions
- Opioid Use Disorder
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Pear Therapeutics, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT05412966
- Locations
- 🇺🇸
Hassman Research Institute, LLC, Berlin, New Jersey, United States
A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic
Not Applicable
Completed
- Conditions
- Opioid-use Disorder
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Pear Therapeutics, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04542642
- Locations
- 🇺🇸
The Substance and Treatment Research Service (STARS) at Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, New York, United States
🇺🇸Addiction Research and Education Foundation, Gig Harbor, Washington, United States
A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic
Not Applicable
Active, not recruiting
- Conditions
- Chronic Insomnia
- First Posted Date
- 2020-03-27
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Pear Therapeutics, Inc.
- Target Recruit Count
- 1590
- Registration Number
- NCT04325464
- Locations
- 🇺🇸
Pear Therapeutics, Inc., Boston, Massachusetts, United States
News
No news found